https://carolinaurologicresearchcenter.com/wp-content/uploads/8.25-Intravescial.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2017-08-28 09:36:482017-09-01 08:53:36Novel Gene Therapy Shows Three-Fold Improvement in Recurrence-Free Survival in High-Risk, Early-Stage Bladder Cancer Patients Where Current Gold-Standard Treatment Fails. With Dr. Neal Shore
Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients...